LEADER 02043nam  22005053u 450 
001 9910463353403321
005 20210106230627.0
010   $a1-78084-207-4
035   $a(CKB)2670000000391289
035   $a(EBL)1179630
035   $a(OCoLC)851970658
035   $a(SSID)ssj0001526192
035   $a(PQKBManifestationID)11834621
035   $a(PQKBTitleCode)TC0001526192
035   $a(PQKBWorkID)11505974
035   $a(PQKB)10487917
035   $a(MiAaPQ)EBC1179630
035   $a(Au-PeEL)EBL1179630
035   $a(EXLCZ)992670000000391289
100   $a20131021d2013||||  u||            |
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aCancer Cachexia$b[electronic resource]
205   $a1st ed.
210   $aLondon $cFuture Medicine Ltd$d2013
215   $a1 online resource (77 p.)
300   $aDescription based upon print version of record.
311   $a1-78084-209-0 
327   $aTitle page; Copyright page; Contents; Foreword. Cancer cachexia; 1. Prevalence and clinical features of cancer cachexia; 2. Pathogenesis of cancer cachexia; 3. Current medications for cancer cachexia; 4. Latest developments in cachexia drug discovery: clinical trials; 5. Comorbidities and prognosis; Index
330   $aCancer cachexia is a multiorganic syndrome associated with neoplastic syndromes, characterized by a marked weight loss, anorexia, asthenia and anemia. This expertly authored book provides a comprehensive review of the mechanisms, mediators and treatment of cancer cachexia. The book represents a comprehensive expert review and summary of the current status of cancer cachexia and its therapy.
608   $aElectronic books.
676   $a616.99407
700   $aArgile?s$b Josep M$01027597
702   $aArgilés$b Josep M
702   $aBusquets$b Silvia
801  0$bAU-PeEL
801  1$bAU-PeEL
801  2$bAU-PeEL
906   $aBOOK
912   $a9910463353403321
996   $aCancer Cachexia$92443141
997   $aUNINA